(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
(Alliance News) - Futura Medical PLC on Tuesday reported a widened loss in its half year report but said it retained a cash runaway extending beyond the launch of its first product. Read More
(Alliance News) - Futura Medical PLC on Wednesday said its erectile dysfunction drug candidate MED3000 showed positive data from a phase 3 study. Read More
(Alliance News) - Stocks in London hovered in early trade on Wednesday, with investors cautious ahead of eurozone inflation data later in the morning. Read More
(Alliance News) - Futura Medical PLC on Monday said it signed a deal with Paris-based medical selfcare organisation Cooper Consumer Health for the commercialisation of MED3000 in the UK, Switzerland and the European Economic Area. Read More
(Alliance News) - European equities made a confident start to the new trading week on Monday, for now setting aside the inflation and economic growth worries that have stifled markets in recent weeks and months. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - Futura Medical PLC shares jumped on Wednesday after the company said it has entered a licensing agreement with A Menarini Korea Ltd or the exclusive rights to commercialise its MED3000 treatment in South Korea. Read More
